DAVID V. GAUVIN; JOSHUA YODER; RACHEL L. TAPP; PHAEDRA I. COLE; PHAEDRA I. COLE. Defining “Best Practices” for Critical Endpoints in Preclinical Screening of New Chemical Entities for Ototoxicity Liability. Otolaryngology, [S. l.], v. 2, n. 2, p. 58–69, 2016. Disponível em: https://openventio.us/index.php/OOJ/article/view/2437. Acesso em: 26 aug. 2026.